RU2007143992A - Вакцинные композиции и способы лечения недержания мочи - Google Patents

Вакцинные композиции и способы лечения недержания мочи Download PDF

Info

Publication number: RU2007143992A
Authority: RU; Russia
Prior art keywords: specified; mammal; lhrh; vaccine; female
Prior art date: 2005-06-01

Application number

RU2007143992/14A

Other languages

English (en)

Russian (ru)

Inventor

Сайед Зиауддин ХАШМИ (AU)

Сайед Зиауддин ХАШМИ

Брэдли Джон НЕТТЛТОН (AU)

Брэдли Джон НЕТТЛТОН

Джон УОЛКЕР (AU)

Джон УОЛКЕР

Original Assignee

Пфайзер Продактс Инк. (Us)

Пфайзер Продактс Инк.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-01

Filing date

2006-05-22

Publication date

2009-07-20

2006-05-22 Application filed by Пфайзер Продактс Инк. (Us), Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк. (Us)

2009-07-20 Publication of RU2007143992A publication Critical patent/RU2007143992A/ru

Links

238000000034 method Methods 0.000 title claims abstract 42
229960005486 vaccine Drugs 0.000 title claims abstract 17
206010046543 Urinary incontinence Diseases 0.000 title claims abstract 8
239000000203 mixture Substances 0.000 title claims 3
241000124008 Mammalia Species 0.000 claims abstract 18
108700012941 GNRH1 Proteins 0.000 claims abstract 16
239000000579 Gonadotropin-Releasing Hormone Substances 0.000 claims abstract 16
239000002671 adjuvant Substances 0.000 claims abstract 8
230000002163 immunogen Effects 0.000 claims abstract 8
108090000623 proteins and genes Proteins 0.000 claims abstract 7
102000004169 proteins and genes Human genes 0.000 claims abstract 7
210000001672 ovary Anatomy 0.000 claims abstract 6
108010086677 Gonadotropins Proteins 0.000 claims abstract 5
102000006771 Gonadotropins Human genes 0.000 claims abstract 5
229960003983 diphtheria toxoid Drugs 0.000 claims abstract 5
239000002622 gonadotropin Substances 0.000 claims abstract 5
229920002491 Diethylaminoethyl-dextran Polymers 0.000 claims abstract 4
230000001580 bacterial effect Effects 0.000 claims abstract 4
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract 4
230000003308 immunostimulating effect Effects 0.000 claims abstract 4
210000002443 helper t lymphocyte Anatomy 0.000 claims abstract 3
102000012673 Follicle Stimulating Hormone Human genes 0.000 claims abstract 2
108010079345 Follicle Stimulating Hormone Proteins 0.000 claims abstract 2
102000009151 Luteinizing Hormone Human genes 0.000 claims abstract 2
108010073521 Luteinizing Hormone Proteins 0.000 claims abstract 2
235000012000 cholesterol Nutrition 0.000 claims abstract 2
229940028334 follicle stimulating hormone Drugs 0.000 claims abstract 2
229940040129 luteinizing hormone Drugs 0.000 claims abstract 2
108090000765 processed proteins & peptides Proteins 0.000 claims abstract 2
239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract 2
229930182490 saponin Natural products 0.000 claims abstract 2
150000007949 saponins Chemical class 0.000 claims abstract 2
210000002966 serum Anatomy 0.000 claims abstract 2
210000001744 T-lymphocyte Anatomy 0.000 claims 1
239000000427 antigen Substances 0.000 claims 1
102000036639 antigens Human genes 0.000 claims 1
108091007433 antigens Proteins 0.000 claims 1
230000002708 enhancing effect Effects 0.000 claims 1
230000028993 immune response Effects 0.000 claims 1
230000002611 ovarian Effects 0.000 claims 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Mycology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Virology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

RU2007143992/14A 2005-06-01 2006-05-22 Вакцинные композиции и способы лечения недержания мочи RU2007143992A (ru)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US68678905P	2005-06-01	2005-06-01
US60/686,789		2005-06-01

Publications (1)

Publication Number	Publication Date
RU2007143992A true RU2007143992A (ru)	2009-07-20

Family

ID=37072557

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
RU2007143992/14A RU2007143992A (ru)	2005-06-01	2006-05-22	Вакцинные композиции и способы лечения недержания мочи

Country Status (15)

Country	Link
EP (1)	EP1890725A2 (fr)
JP (2)	JP2008545738A (fr)
KR (1)	KR20080007648A (fr)
CN (1)	CN101189026A (fr)
AR (1)	AR054370A1 (fr)
AU (1)	AU2006253914A1 (fr)
BR (1)	BRPI0611390A2 (fr)
CA (1)	CA2609244A1 (fr)
MX (1)	MX2007015151A (fr)
NO (1)	NO20075923L (fr)
RU (1)	RU2007143992A (fr)
TW (1)	TW200716164A (fr)
UY (1)	UY29574A1 (fr)
WO (1)	WO2006129162A2 (fr)
ZA (1)	ZA200710213B (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994025060A1 (fr) *	1993-04-27	1994-11-10	Ladd Anna E	Peptides immunogenes de la lhrh et stimulators d'immunite universelle de synthese pour vaccins
AUPO776897A0 (en) *	1997-07-09	1997-07-31	Csl Limited	A method of achieving production gains in livestock and agents useful for same
AUPP807399A0 (en) *	1999-01-08	1999-02-04	Csl Limited	Improved immunogenic lhrh composition and methods relating thereto
JP4699612B2 (ja) *	1999-02-05	2011-06-15	ザユニバーシティオブメルボーン	Ｔヘルパー細胞エピトープ
DE60113142T2 (de) *	2000-10-30	2006-07-06	University Of Zurich	Verwendung von gnrh-analogue zur behandlung der harninkontinenz
US20030144203A1 (en) *	2001-12-19	2003-07-31	Voyager Pharmaceutical Corporation	Methods for slowing senescence and treating and preventing diseases associated with senescence

2006
- 2006-05-22 CN CNA2006800194072A patent/CN101189026A/zh active Pending
- 2006-05-22 WO PCT/IB2006/001398 patent/WO2006129162A2/fr not_active Ceased
- 2006-05-22 KR KR1020077027852A patent/KR20080007648A/ko not_active Ceased
- 2006-05-22 EP EP06744784A patent/EP1890725A2/fr not_active Withdrawn
- 2006-05-22 AU AU2006253914A patent/AU2006253914A1/en not_active Abandoned
- 2006-05-22 BR BRPI0611390-7A patent/BRPI0611390A2/pt not_active IP Right Cessation
- 2006-05-22 RU RU2007143992/14A patent/RU2007143992A/ru not_active Application Discontinuation
- 2006-05-22 CA CA002609244A patent/CA2609244A1/fr not_active Abandoned
- 2006-05-22 MX MX2007015151A patent/MX2007015151A/es unknown
- 2006-05-22 JP JP2008514217A patent/JP2008545738A/ja active Pending
- 2006-05-30 TW TW095119259A patent/TW200716164A/zh unknown
- 2006-05-30 AR ARP060102239A patent/AR054370A1/es unknown
- 2006-06-01 UY UY29574A patent/UY29574A1/es not_active Application Discontinuation
2007
- 2007-11-16 NO NO20075923A patent/NO20075923L/no not_active Application Discontinuation
- 2007-11-27 ZA ZA200710213A patent/ZA200710213B/xx unknown
2008
- 2008-12-17 JP JP2008320394A patent/JP2009137972A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
UY29574A1 (es)	2006-12-29
CN101189026A (zh)	2008-05-28
JP2008545738A (ja)	2008-12-18
AU2006253914A1 (en)	2006-12-07
BRPI0611390A2 (pt)	2010-09-08
ZA200710213B (en)	2008-09-25
EP1890725A2 (fr)	2008-02-27
CA2609244A1 (fr)	2006-12-07
TW200716164A (en)	2007-05-01
NO20075923L (no)	2007-12-18
WO2006129162A3 (fr)	2007-02-08
WO2006129162A2 (fr)	2006-12-07
JP2009137972A (ja)	2009-06-25
KR20080007648A (ko)	2008-01-22
AR054370A1 (es)	2007-06-20
MX2007015151A (es)	2008-02-15

Legal Events

Date	Code	Title	Description
2009-10-10	FA92	Acknowledgement of application withdrawn (lack of supplementary materials submitted)	Effective date: 20090826

Publication	Publication Date	Title
AU645967B2 (en)	1994-02-03	Immunogenic compositions against gastrin peptides
Oppenheim	1972	Modulation of in vitro lymphocyte transformation by antibodies: enhancement by antigen-antibody complexes and inhibition by antibody excess
US5518725A (en)	1996-05-21	Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
ZA200105543B (en)	2003-01-22	Improved saponin adjuvant compositions and methods relating thereto.
WO2003089593A3 (fr)	2003-12-24	Immunotherapie amelioree par adjuvant
JP2002534481A5 (fr)	2007-03-01
Talwar	1997	Vaccines for control of fertility and hormone‐dependent cancers
JPH04505767A (ja)	1992-10-08	新規医薬
Stevens	1975	Fertility control through active immunization using placenta proteins
RU2007143992A (ru)	2009-07-20	Вакцинные композиции и способы лечения недержания мочи
Ferro et al.	1998	Investigation into suitable carrier molecules for use in an anti-gonadotrophin releasing hormone vaccine
Kreiss et al.	2009	The humoral immune response of the Tasmanian devil (Sarcophilus harrisii) against horse red blood cells
Lamm et al.	1993	Keyhole limpet hemocyanin immunotherapy of murine bladder cancer
JPH01500663A (ja)	1989-03-09	動物の生殖機能の調節
Dietrich	1966	The Immune Response to Azo-Human γ-Globulin Conjugates in Mice Tolerant to Human γ-Globulin
Miller et al.	2006	Contraceptive effect of a recombinant GnRH vaccine in adult female pigs
CA2208431A1 (fr)	1996-06-27	Vaccin presentant une immunogenicite accrue
Talwar et al.	1988	Birth control vaccines inducing antibodies against chorionic gonadotropin
Říhová et al.	1985	Low IgG response of the mouse strain C57BL/10ScSn after immunization with protein antigens
CA2460042A1 (fr)	2002-04-04	Inhibition de la presentation de l'antigene avec des polymeres faiblement catabolises
JP2001518516A5 (fr)	2006-01-05
Cohen et al.	1973	Antigen-Macrophage Interaction: I. Hapten-Specific Inhibition of Antigen Interaction with Macrophages from Immune Animals
Wyczółkowska et al.	1975	Inhibition by nicotinamide of an homologous PCA reaction and antigen-induced histamine release from rat peritoneal mast cells
US20130011430A1 (en)	2013-01-10	HUMAN CHORIONIC GONADOTROPIN (hCG) BASED VACCINE FOR PREVENTION AND TREATMENT OF CANCER
Katsh et al.	1968	Pituitary gonadotropin content of aspermatogenic guinea pigs